Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Steiner, Hannes; Zangerl, Florian; Stöhr, Brigitte; Granig, Thomas; Ho, Henry Sun Sien; Bartsch, Georg; Peschel, Reinhard

doi:10.1016/j.juro.2008.06.040

Cited by 50 publications

(42 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…35 The surgery was successfully finished in all 19 of their patients and no conversion was necessary, and there was no recurrence after a mean follow-up of 17.2 months. Another study compared the unilateral template with a bilateral template in PC-RLA.…”

Section: Technique Templatementioning

confidence: 83%

Minimally Invasive Retroperitoneal Lymphadenectomy

Kunit

Janetschek

2015

Urologic Clinics of North America

View full text Add to dashboard Cite

Section: Technique Templatementioning

confidence: 83%

Minimally Invasive Retroperitoneal Lymphadenectomy

Kunit

Janetschek

2015

Urologic Clinics of North America

View full text Add to dashboard Cite

“…Given the high potential for complications in post-chemotherapy patients, LRPLND should only be attempted in highly selected patients by surgeons with significant laparoscopic experience. [Steiner et al 2008]. The authors found teratoma, necrosis/fibrosis, and active tumor in 4, 14 and 1 patient respectively.…”

Section: Lrplnd Techniquementioning

confidence: 95%

“…In most contemporary series adjuvant chemotherapy continues to be given to patients with any nodal involvement at the time of LRPLND. Of the 122 node positive patients reported in the series listed in Table 1 following LRPLND [Skolarus et al 2008 [Steiner et al 2008]. None of the five patients were given adjuvant chemotherapy and all are without recurrence at follow-up intervals of 2-35 months.…”

Section: Lrplnd Techniquementioning

confidence: 99%

Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors

Guzzo¹,

Allaf²

2009

Therapeutic Advances in Urology

View full text Add to dashboard Cite

Abstract:Objectives: Open retroperitoneal lymph node dissection has been traditionally used for the management of patients with nonseminomatous germ-cell tumors (NSGCTs). Over the last decade, laparoscopic retroperitoneal lymph node dissection (LRPLND) has gained popularity in several highly specialized centers. Methods: We retrospectively reviewed the English-language literature with regard to LRPLND. The perioperative and oncologic outcomes for patients with low stage NSGCTs who underwent LRPLND are summarized in this review with particular emphasis on contemporary studies. Results: Initially only used for staging, LRPLND has evolved to a therapeutic procedure capable of replicating the templates used for open RPLND. Perioperative outcomes including operative time, conversion rates and complications improve with surgeon experience and are acceptable at high volume centers. Oncologic outcomes are promising, but require longer term follow-up and the administration of adjuvant chemotherapy in many studies limits comparison to that of the open technique. Conclusion: LRPLND has been demonstrated to be feasible and safe at large volume institutions with experienced laparoscopic surgeons. LRPLND was originally performed as a staging procedure in patients with NSGCTs but has evolved into a therapeutic operation with early reports demonstrating short hospital stays and minimal morbidity. Further studies in larger cohorts of patients with longer term follow up are required to define the exact role of LRPLND.

show abstract

“…The use of laparoscopy in postchemotherapy RPLND appears technically feasible but uncertain with regards to its long-term outcome [51,52]. Most of the current experience is in the primary setting as opposed to after chemotherapy.…”

Section: Laparoscopymentioning

confidence: 99%

Postchemotherapy Surgery for Germ Cell Tumors—What Have We Learned in 35 Years?

et al. 2014

View full text Add to dashboard Cite

Postchemotherapy surgery for advanced testicular cancer has evolved over the last couple of decades. Patients with nonseminomatous germ cell tumors and residual retroperitoneal mass ≥1 cm should undergo postchemotherapy retroperitoneal lymph node dissection (RPLND). For seminoma, RPLND is considered in those patients with masses ≥3 cm that are also positron emission tomography positive. Masses that occur outside of the retroperitoneum should be completely resected with the possible exception of bilateral lung masses when resection of the first mass shows necrosis. The role of surgery in patients with extragonadal germ cell tumors is most vital in those with primary mediastinal nonseminomatous germ cell tumors. Importantly, patient selection, surgical planning, and consideration of referral to centers with this expertise are important to optimize success.

show abstract

Results of Bilateral Nerve Sparing Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Abstract: Bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection is feasible and associated with low morbidity if performed by experienced hands. The oncological efficacy of this approach is promising and currently under evaluation.

Cited by 50 publications

References 18 publications

Minimally Invasive Retroperitoneal Lymphadenectomy

Minimally Invasive Retroperitoneal Lymphadenectomy

Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors

Postchemotherapy Surgery for Germ Cell Tumors—What Have We Learned in 35 Years?

Contact Info

Product

Resources

About